Examination Report |
1 | Additional Representation Sheet | 16 Dec 2013 |
1 | TM-1 | 16 Dec 2013 |
10 | Hearing Notice | 10 Dec 2019 |
11 | Hearing Notice | 18 Oct 2021 |
12 | written submision | 10 Nov 2021 |
13 | Hearing Notice | 21 Dec 2021 |
14 | Order | 27 Jan 2022 |
2 | Additional Representation Sheet | 16 Dec 2013 |
2 | Power of Attorney | 16 Dec 2013 |
3 | Power of Attorney | 16 Dec 2013 |
3 | TM-1 | 16 Dec 2013 |
4 | Reply to Exam Report (MIS-R) | 16 Sep 2015 |
5 | REPLY TO OFFICIAL COMMUNICATION (MIS-O) | 14 Mar 2018 |
6 | REPLY TO OFFICIAL COMMUNICATION (MIS-O) | 16 Mar 2018 |
7 | Authorization Letter | 21 Mar 2018 |
8 | Journal Copy | 18 May 2018 |
9 | TM-O(NOTICE OF OPPOSITION) | 09 Jul 2018 |
1 | Hearing Notice (Show Cause) | 5808359 | 2542163 | 01 Feb 2018 |
2 | Tribunal Accepted Notice for : 2643234 | 6089615 | 2651209 | 20 Mar 2018 |
3 | Opposition Notice | 6645391 | 2995821 | 11 Jul 2018 |
4 | Opposition Counter Statement | 6960890 | 3182372 | 10 Sep 2018 |
5 | Generate Report | 9368009 | 06 Dec 2019 |
Trademark was applied on 16 December 2013 with IP India.
Proprietor of Moxirobe is AUROBINDO PHARMA.
Class(es) in which the trademark was applied to is 5.
Status of Moxirobe is Abandoned.
Application number alloted to the trademark is 2643234.
Daswani & Daswani is the Trademark agent/attorney.
Trademark has been filed in the following category:
WORD